CannaPharmaRx Inc (OTC Pink Sheets: CPMD) is a cannabis company that acquires, develops, and operates cannabis cultivation facilities in Canada. Revenue is generated through the sale of medical cannabis and craft cannabis products grown at its licensed indoor facility. The company holds operating and cannabis licenses from Health Canada and the Canada Revenue Agency, both received in December 2022, and commenced production during the year ended December 31, 2023. The principal facility is a 55,000 square foot indoor cannabis farm in Cremona, Alberta, Canada, operating under a 20-year lease entered January 6, 2022, with six of ten growing rooms and one drying and packing room active as of the 10-K filed March 31, 2026. As of December 31, 2025, the company carried an accumulated deficit of $112,315,590 and disclosed material uncertainty about its ability to continue as a going concern. The company is classified as a penny stock on OTC Markets and relies on convertible notes, related-party loans, and equity issuances to fund operations.

Revenue model

Product sales of medical cannabis and craft cannabis grown at the Cremona, Alberta facility. The filing also references deferred revenue and a royalty agreement related to an IMC Cannabis transaction (Security and Royalty Agreement with Koze Investments LLC, dated March 17, 2025). Primary financing has come from convertible notes at interest rates of 12% to 24% and notes payable to private individuals.

Products and services

Medical cannabis and craft cannabis products cultivated at a 55,000 square foot indoor facility in Cremona, Alberta, Canada. The facility contains 10 growing rooms and one drying and packing room, with six growing rooms operational as of the fiscal year ended December 31, 2025.

Customers and end markets

Medical cannabis end market in Canada. No specific customer names, customer counts, or customer concentration data are disclosed in the filing excerpts.

Value-chain role

Vertically integrated cannabis cultivator and processor operating its own licensed indoor grow facility. Holds a Health Canada operating license (issued December 9, 2022) and a Canada Revenue Agency cannabis license (issued December 22, 2022).

Geographic exposure

Operations entirely in Alberta, Canada. Principal executive office at 4439 Township Rd 304, Mountain View County, Alberta, Canada T0M 0R0. Production facility located in Cremona, Alberta.

Source: SEC 10-K, filed 2026-03-31

Industry: Pharmaceutical Preparations Peers: Pharmagreen Biotech Inc Target Group Inc